SYMBOL:

    Up to 100 tickers separated by a space .....Watch Post-Market activities
Site Map FAQ Contact us Home Personalize
Company
Industry
Earnings
US Markets
Most Active
Portfolio
Tools
ETFs
Ratings
MYRIAD GENETICS
(NQNM:MYGN Last Sale: 15.25 +0)
Fundamentals Charts Tech Analysis Industry Earnings
Company Profile   Details

Company Web Site
NQNM: (MYGN : $15.25)
$1,136,889 million Market Cap at Market Close, July 1, 2022
Employs 870.
Biomedics SubIndustry up .00% / Health Industry up .00% Today
320 Wakara Way Research Report Earnings Snapshot - Last 11/04/18
Salt Lake City, UT 84108 Fact Sheet
Phone: (801) 584-3600 Financial Statements
Fax: (801) 584-3640 Peer Comparison
Annual Reports

H.A. D'Andrade, Chmn., Peter D. Meldrum, Pres./CEO, James S. Evans, CFO
Patents on genes undermined by ruling November 1, 2010, and status remains unresolved, subject to ruling on appeal. Perceived as offering expensive genetic tests protected from competition by patents which may be invalidated. Focuses on the development of novel therapeutic products derived from its proprietary genomic and proteomic technologies. Founded in 1991. Spun-off MYRIAD PHARMACEUTICALS INC (MYRX) 1-for-4 June 30, 2009, to separate the molecular diagnostic business from the research and drug development businesses.
Historical Charts    Technical Analysis
No Historical Data available for MYGN

Type of Stock Symbol Last Sale Last Close Net +/- % +/- Low High Volume 52wk Low 52wk High Shares(M)
Common MYGN $15.25 $15.25 0 .0 $14.41 $15.3 1,298,829 $14.41 $15.3 74,550,111
Capitalization
Earnings Summary ()
*** No Earnings Available***
-10126
Common Stock #############

Split, Dividend and Symbol Change Information
Date Symbol Transaction Dividend Split New Symbol
25-MAR-09 MYGN Split 2 for 1
11-SEP-00 MYGN Split 2 for 1

A570
Google



QUICK NAVIGATION SITE SEARCH   Enter Keyword:
   
Home    Subscribe    Browser Help    Subscriber Services    B-to-B    Banks    Brokerage    Telco    Site Map    Legal    Contact/Email
Copyright © 1996 - 2025 Stock Smart with all rights reserved
Feed is currently being brought back up
Provided by Nanex